Gingival crevicular fluid IL-6, tPA, PAI-2, albumin levels following initial periodontal treatment in chronic periodontitis patients with or without type 2 diabetes

Inflamm Res. 2011 Feb;60(2):143-51. doi: 10.1007/s00011-010-0248-7. Epub 2010 Sep 17.

Abstract

Objectives: To evaluate initial periodontal treatment effects on gingival crevicular fluid (GCF) interleukin-6 (IL-6), tissue-type plasminogen activator (tPA), plasminogen activator inhibitor-2 (PAI-2), albumin levels in type 2 diabetic patients.

Design and methods: GCF samples were collected from 20 type 2 diabetic, 22 non-diabetic non-smokers all with chronic periodontitis at baseline, 1-, 3-months following initial periodontal treatment. Biochemical analysis was performed by ELISA. Data were tested by Mann-Whitney U, Wilcoxon tests.

Results: The total amounts of albumin, IL-6, tPA, PAI-2 decreased significantly in diabetics after treatment (1- and 3-months) whereas, only PAI-2 decreased in non-diabetic group at 3-months (p < 0.05). There were statistically significant differences between the diabetics and non-diabetics at all time points for albumin, PAI-2 and at 1-, 3-months for GCF volume (p < 0.050) but only at baseline for IL-6 (p < 0.050).

Conclusion: Present data suggest clinical improvements are less apparent in diabetic chronic periodontitis patients as reflected by disease markers in GCF and by an increase in concentrations of inflammatory proteins IL-6, tPA, and PAI-2 in GCF of this patient group following initial periodontal treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Albumins / metabolism*
  • Chronic Periodontitis / metabolism
  • Chronic Periodontitis / therapy*
  • Diabetes Mellitus, Type 2 / metabolism*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Gingival Crevicular Fluid / chemistry*
  • Humans
  • Interleukin-6 / metabolism*
  • Male
  • Middle Aged
  • Plasminogen Activator Inhibitor 2 / metabolism*
  • Tissue Plasminogen Activator / metabolism*

Substances

  • Albumins
  • Interleukin-6
  • Plasminogen Activator Inhibitor 2
  • Tissue Plasminogen Activator